Positron-emission tomography in gynaecologic malignancies

Anna Margherita Maffione, Michela Piva, Charoula Stavroula Tsamita, Cristina Nanni, Paolo Castellucci, Valentina Ambrosini, Egesta Lopci, Alessandra Musto, Lucia Rampin, Gaia Grassetto, Maria Cristina Marzola, Arianna Massaro, Elena Cracco, Adil Al-Nahhas, Stefano Fanti, Domenico Rubello

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Introduction: The role of 18F-FDG PET in the management of gynaecologic malignancies remains unclear mainly due to the failure of clinicians to appreciate the significance of this imaging tool. However, this under utilisation is being actively re-addressed with a large number of reviews and studies, particularly in the last few years. Methods and Results: PET has been shown to have high sensitivity and specificity in the evaluation of relapse and nodal disease in cervical cancer, while other uses such as staging and monitoring response to therapies being under further investigation. Similarly, promising results have been published in the use of PET in patients affected by endometrial cancer and uterine sarcomas for detecting lymph nodes metastasis and recurrent disease. In ovarian cancer, PET appears to have a great potential in staging and assessment of disease relapse. An important utility of PET in gynaecologic tumours, which is shared with a large number of other malignancies, is its value in positively changing the patients' management. Conclusion: The surge in studies using PET in gynaecological malignancies is in its early stages, and further studies are required to optimise the role of PET in these conditions.

Original languageEnglish
Pages (from-to)521-528
Number of pages8
JournalArchives of Gynecology and Obstetrics
Volume280
Issue number4
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Positron-Emission Tomography
Neoplasms
Recurrence
Fluorodeoxyglucose F18
Endometrial Neoplasms
Uterine Cervical Neoplasms
Sarcoma
Ovarian Neoplasms
Lymph Nodes
Neoplasm Metastasis
Sensitivity and Specificity
Therapeutics

Keywords

  • Cervical cancer
  • Endometrial cancer
  • Gynaecologic malignancy
  • Oncology
  • Ovarian cancer
  • PET/CT

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Maffione, A. M., Piva, M., Tsamita, C. S., Nanni, C., Castellucci, P., Ambrosini, V., ... Rubello, D. (2009). Positron-emission tomography in gynaecologic malignancies. Archives of Gynecology and Obstetrics, 280(4), 521-528. https://doi.org/10.1007/s00404-009-0979-2

Positron-emission tomography in gynaecologic malignancies. / Maffione, Anna Margherita; Piva, Michela; Tsamita, Charoula Stavroula; Nanni, Cristina; Castellucci, Paolo; Ambrosini, Valentina; Lopci, Egesta; Musto, Alessandra; Rampin, Lucia; Grassetto, Gaia; Marzola, Maria Cristina; Massaro, Arianna; Cracco, Elena; Al-Nahhas, Adil; Fanti, Stefano; Rubello, Domenico.

In: Archives of Gynecology and Obstetrics, Vol. 280, No. 4, 10.2009, p. 521-528.

Research output: Contribution to journalArticle

Maffione, AM, Piva, M, Tsamita, CS, Nanni, C, Castellucci, P, Ambrosini, V, Lopci, E, Musto, A, Rampin, L, Grassetto, G, Marzola, MC, Massaro, A, Cracco, E, Al-Nahhas, A, Fanti, S & Rubello, D 2009, 'Positron-emission tomography in gynaecologic malignancies', Archives of Gynecology and Obstetrics, vol. 280, no. 4, pp. 521-528. https://doi.org/10.1007/s00404-009-0979-2
Maffione AM, Piva M, Tsamita CS, Nanni C, Castellucci P, Ambrosini V et al. Positron-emission tomography in gynaecologic malignancies. Archives of Gynecology and Obstetrics. 2009 Oct;280(4):521-528. https://doi.org/10.1007/s00404-009-0979-2
Maffione, Anna Margherita ; Piva, Michela ; Tsamita, Charoula Stavroula ; Nanni, Cristina ; Castellucci, Paolo ; Ambrosini, Valentina ; Lopci, Egesta ; Musto, Alessandra ; Rampin, Lucia ; Grassetto, Gaia ; Marzola, Maria Cristina ; Massaro, Arianna ; Cracco, Elena ; Al-Nahhas, Adil ; Fanti, Stefano ; Rubello, Domenico. / Positron-emission tomography in gynaecologic malignancies. In: Archives of Gynecology and Obstetrics. 2009 ; Vol. 280, No. 4. pp. 521-528.
@article{33a58a49e9234db8bd4c1cfe4fe9475f,
title = "Positron-emission tomography in gynaecologic malignancies",
abstract = "Introduction: The role of 18F-FDG PET in the management of gynaecologic malignancies remains unclear mainly due to the failure of clinicians to appreciate the significance of this imaging tool. However, this under utilisation is being actively re-addressed with a large number of reviews and studies, particularly in the last few years. Methods and Results: PET has been shown to have high sensitivity and specificity in the evaluation of relapse and nodal disease in cervical cancer, while other uses such as staging and monitoring response to therapies being under further investigation. Similarly, promising results have been published in the use of PET in patients affected by endometrial cancer and uterine sarcomas for detecting lymph nodes metastasis and recurrent disease. In ovarian cancer, PET appears to have a great potential in staging and assessment of disease relapse. An important utility of PET in gynaecologic tumours, which is shared with a large number of other malignancies, is its value in positively changing the patients' management. Conclusion: The surge in studies using PET in gynaecological malignancies is in its early stages, and further studies are required to optimise the role of PET in these conditions.",
keywords = "Cervical cancer, Endometrial cancer, Gynaecologic malignancy, Oncology, Ovarian cancer, PET/CT",
author = "Maffione, {Anna Margherita} and Michela Piva and Tsamita, {Charoula Stavroula} and Cristina Nanni and Paolo Castellucci and Valentina Ambrosini and Egesta Lopci and Alessandra Musto and Lucia Rampin and Gaia Grassetto and Marzola, {Maria Cristina} and Arianna Massaro and Elena Cracco and Adil Al-Nahhas and Stefano Fanti and Domenico Rubello",
year = "2009",
month = "10",
doi = "10.1007/s00404-009-0979-2",
language = "English",
volume = "280",
pages = "521--528",
journal = "Archives of Gynecology",
issn = "0170-9925",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Positron-emission tomography in gynaecologic malignancies

AU - Maffione, Anna Margherita

AU - Piva, Michela

AU - Tsamita, Charoula Stavroula

AU - Nanni, Cristina

AU - Castellucci, Paolo

AU - Ambrosini, Valentina

AU - Lopci, Egesta

AU - Musto, Alessandra

AU - Rampin, Lucia

AU - Grassetto, Gaia

AU - Marzola, Maria Cristina

AU - Massaro, Arianna

AU - Cracco, Elena

AU - Al-Nahhas, Adil

AU - Fanti, Stefano

AU - Rubello, Domenico

PY - 2009/10

Y1 - 2009/10

N2 - Introduction: The role of 18F-FDG PET in the management of gynaecologic malignancies remains unclear mainly due to the failure of clinicians to appreciate the significance of this imaging tool. However, this under utilisation is being actively re-addressed with a large number of reviews and studies, particularly in the last few years. Methods and Results: PET has been shown to have high sensitivity and specificity in the evaluation of relapse and nodal disease in cervical cancer, while other uses such as staging and monitoring response to therapies being under further investigation. Similarly, promising results have been published in the use of PET in patients affected by endometrial cancer and uterine sarcomas for detecting lymph nodes metastasis and recurrent disease. In ovarian cancer, PET appears to have a great potential in staging and assessment of disease relapse. An important utility of PET in gynaecologic tumours, which is shared with a large number of other malignancies, is its value in positively changing the patients' management. Conclusion: The surge in studies using PET in gynaecological malignancies is in its early stages, and further studies are required to optimise the role of PET in these conditions.

AB - Introduction: The role of 18F-FDG PET in the management of gynaecologic malignancies remains unclear mainly due to the failure of clinicians to appreciate the significance of this imaging tool. However, this under utilisation is being actively re-addressed with a large number of reviews and studies, particularly in the last few years. Methods and Results: PET has been shown to have high sensitivity and specificity in the evaluation of relapse and nodal disease in cervical cancer, while other uses such as staging and monitoring response to therapies being under further investigation. Similarly, promising results have been published in the use of PET in patients affected by endometrial cancer and uterine sarcomas for detecting lymph nodes metastasis and recurrent disease. In ovarian cancer, PET appears to have a great potential in staging and assessment of disease relapse. An important utility of PET in gynaecologic tumours, which is shared with a large number of other malignancies, is its value in positively changing the patients' management. Conclusion: The surge in studies using PET in gynaecological malignancies is in its early stages, and further studies are required to optimise the role of PET in these conditions.

KW - Cervical cancer

KW - Endometrial cancer

KW - Gynaecologic malignancy

KW - Oncology

KW - Ovarian cancer

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=69249248095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249248095&partnerID=8YFLogxK

U2 - 10.1007/s00404-009-0979-2

DO - 10.1007/s00404-009-0979-2

M3 - Article

VL - 280

SP - 521

EP - 528

JO - Archives of Gynecology

JF - Archives of Gynecology

SN - 0170-9925

IS - 4

ER -